Connect with us

Technology

Briefing: Policy changes needed to ensure the ethical and effective use of healthcare AI

Published

on

Room 330, Cannon House Office Building

WASHINGTON, Oct. 12, 2026 /PRNewswire/ — Artificial intelligence (AI) has the potential to revolutionize healthcare, but thoughtful regulations are needed in order for this technology to live up to its promise — particularly for America’s most vulnerable patients. Join the Association for Diagnostics & Laboratory Medicine (ADLM) to learn about how AI is currently being used in healthcare, the benefits and limitations of this evolving technology, and what Congress needs to do to ensure that healthcare AI is used judiciously and ethically.   

AI is rapidly changing how healthcare organizations manage their operations, analyze data, and diagnose disease. Because clinical laboratories generate approximately 80% of the data used to inform medical decisions, laboratory medicine is at the center of efforts to harness AI to improve patient care.

At this briefing, leading experts in laboratory medicine will discuss how AI is transforming their field and healthcare overall, as well as the top five policy changes needed to advance AI in an efficient and effective manner. Speakers will also provide a case study highlighting how AI is used in pediatric health, illustrating both the promise of this technology and the challenges that remain.

Attendees will gain a better understanding of the role that Congress can play to establish appropriate oversight and regulation of AI, as well as what is needed to ensure that this technology benefits all patients — especially children.

When: Luncheon briefing: 12 – 1 p.m., Tuesday, October 13

Where: Room 330, Cannon House Office Building

Who:

Moderator: Dr. Dennis J. Dietzen, chair of pathology and laboratory medicine, Phoenix Children’s HospitalSpeakers: Dr. Sarah Wheeler, clinical pathology medical director, University of Pittsburgh Medical Center Children’s Hospital of PittsburghDr. Stephen Master, vice chair for innovation, department of pathology and laboratory medicine, Children’s Hospital of Philadelphia

RSVP: Email Christine DeLong, ADLM director of editorial and media relations at cdelong@myadlm.org.

About the Association for Diagnostics & Laboratory Medicine (ADLM)
Dedicated to achieving better health for all through laboratory medicine, ADLM unites more than 70,000 clinical laboratory professionals, physicians, research scientists, and business leaders from 110 countries around the world. Our community is at the forefront of laboratory medicine’s diverse subdisciplines, including clinical chemistry, molecular diagnostics, mass spectrometry, clinical microbiology, and data science, and is comprised of individuals holding the spectrum of lab-related professional degrees, certifications, and credentials. Since 1948, ADLM has championed the advancement of laboratory medicine by fostering scientific collaboration, knowledge sharing, and the development of innovative solutions that enhance health outcomes. For more information, visit www.myadlm.org.

Christine DeLong
ADLM
Director, Editorial and Media Relations
(p) 202.835.8722
cdelong@myadlm.org

Bill Malone
ADLM
Senior Director, Strategic Communications
(p) 202.835.8756
bmalone@myadlm.org

View original content to download multimedia:https://www.prnewswire.com/news-releases/briefing-policy-changes-needed-to-ensure-the-ethical-and-effective-use-of-healthcare-ai-302905939.html

SOURCE Association for Diagnostics & Laboratory Medicine (ADLM)

Continue Reading

Technology

HCLTech delivers strong Q2 led by record deal bookings of $3.3 billion

Published

on

By

EBIT margin expands to 18.2%; annualized advanced AI revenue at $876M

NEW YORK and NOIDA, India, Oct. 12, 2026 /CNW/ — HCLTech (NSE: HCLTECH) (BSE: HCLTECH), a leading global technology company, today reported financial results for the quarter ended September 30, 2026. USD revenue was at $3.7 billion, up 2.2% YoY, while revenue in constant currency (CC) grew 2.6% YoY.

“We delivered a strong quarter with new bookings of $3.3 billion, up 27% YoY, taking first half bookings to a record high. EBIT margin expanded 131 bps QoQ to 18.2%. Services grew 3% QoQ with growth across verticals and geographies, while overall revenue grew 2.3% QoQ. Advanced AI revenue grew 28.4% QoQ and 78% YoY in constant currency. Our AI propositions are resonating well with our clients, giving us confidence in our growth trajectory,” said C Vijayakumar, CEO & Managing Director, HCLTech.

Services revenue growth was led by a steady momentum in IT and Business Services, which grew at 4.4% YoY in CC, followed by Engineering and R&D Services at 2.1% YoY (CC). HCLSoftware’s annual recurring revenue stood at $1.13 billion. Revenue per employee per annum was at $65.4K, up 2.4% YoY. 

Advanced AI revenue for the quarter was at $219 million, leading to an annualized advanced AI revenue of $876 million.

Industry vertical growth was led by Retail and Consumer Packaged Goods, with 14% YoY (CC) growth, followed by Financial Services at 7.1 % YoY (CC) and Technology and Services at 5.9% YoY (CC). In terms of geographies, the U.S. grew by 3.5% YoY (CC). India grew the fastest at 21.8% YoY (CC) while the Rest of the World grew by 11.4% YoY (CC).

The company revised its FY27 revenue growth guidance to 2.5%-4% YoY in CC and Services revenue growth guidance to 3%-4% YoY in CC. EBIT margin is expected to be between 17.5% and 18.5%. HCLTech announced a dividend of ₹12 per share for the quarter.

“HCLTech delivered Q2 FY27 revenue of ₹35,620 crores, up 3% QoQ and 11.5% YoY. Our superior revenue growth with improved profitability led to our highest-ever quarterly net income of ₹5,132 crores, up 11% QoQ and 21.2% YoY,” said Shiv Walia, Chief Financial Officer, HCLTech.

The company added 6,450 people to its workforce, including 6,136 freshers, during Q2, FY27. Gender diversity reached 30% during the quarter.

HCLTech also announced a Global Premier Partnership with Anthropic to accelerate enterprise adoption of Agentic AI with a focus on safety, cybersecurity and governance. HCLTech’s services teams will build industry solutions and offerings powered by Claude, Cowork and Claude Code, while HCLSoftware, as an Anthropic ISV partner, will embed these into select enterprise products.

Key Advanced AI deal wins:

A U.S.-based AI-native company selected HCLTech as a strategic partner for its AI Factory.A U.S.-based neocloud provider selected HCLTech to build and scale its AI-native architecture and infrastructure capabilities that enable hyperscalers and enterprises to unlock the full potential of AI at scale.A Europe-based manufacturing company selected HCLTech to transform quality assurance at scale with an AI-powered visual inspection platform, VisionX.

Other key deal wins:

A Europe-headquartered, Fortune Global 50 firm selected HCLTech to establish an AI-driven operating model to transform and manage its Global Digital Workplace and Enterprise Networks.A Europe-based FMCG major selected HCLTech to transform its global IT operations through a unified, AI-led operating model spanning applications, cloud and networks, digital workplace and cybersecurity.A global aerospace and defense major selected HCLTech to provide full lifecycle managed services for its SAP S/4HANA landscape, including ERP application project delivery, support and maintenance.

HCLTech has been named to TIME’s World’s Best Companies list for the third consecutive year. It has also been named among Forbes’ World’s Best Employers and World’s Best Management Consulting Firms, while Newsweek recognized it among America’s Greatest Workplaces for Leadership and America’s Greatest Workplaces for Perks & Benefits.

About HCLTech

HCLTech is a global technology company, home to more than 230,000 people across 60+ countries, delivering industry-leading capabilities centered around AI, digital, engineering, cloud and software, powered by a broad portfolio of technology services and products. We work with clients across all major verticals, providing industry solutions for Financial Services, Manufacturing, Life Sciences and Healthcare, Technology and Services, Semiconductor, Telecom and Media, Retail and CPG, Mobility and Public Services. Consolidated revenues as of 12 months ending September 2026 totaled $14.8 billion. To learn how we can supercharge progress for you, visit hcltech.com.

For further details, please contact:

Meredith Bucaro, Americas
meredith-bucaro@hcltech.com

Elka Ghudial, EMEA
elka.ghudial@hcltech.com

James Galvin, APAC
james.galvin@hcltech.com

Nitin Shukla, India
nitin-shukla@hcltech.com

View original content to download multimedia:https://www.prnewswire.com/news-releases/hcltech-delivers-strong-q2-led-by-record-deal-bookings-of-3-3-billion-302906028.html

SOURCE HCLTech

Continue Reading

Technology

ASES to Honor Six Austin-Area Clean Energy Leaders at SOLAR 2026

Published

on

By

Host City Inaugural awards recognize leadership in clean energy policy, implementation, equity, education, and innovation across Austin, TX, and Travis County

BOULDER, Colo., Oct. 12, 2026 /PRNewswire/ — The American Solar Energy Society (ASES) Board of Directors today announced six recipients of its inaugural host-city recognition awards, honoring clean energy leadership across Austin and the surrounding region. The awards will be presented at the SOLAR 2026 opening reception on Monday, October 19, at 6 p.m. at the Palmer Events Center in Austin, Texas.

“Every ASES SOLAR conference brings us into a community that is shaping the energy transition in its own way,” said Karen Soares, chair of the ASES Board of Directors. “These honorees demonstrate how local leadership, public policy, education, equity and effective programs can turn clean energy goals into measurable progress. We are proud to recognize their contributions to Austin and Travis County and to celebrate their work with the ASES community.”

The 2026 ASES Board-recognized honorees are:

Stuart Reilly, Austin Energy, recipient of the ASES Municipal Utility Clean Energy Implementation AwardKirk Watson, Mayor of Austin, recipient of the ASES Host City Clean Energy Leadership AwardSarah Eckhardt, Texas State Senator, recipient of the ASES Clean Energy Policy Leadership AwardKecia Prince, Strategic Housing Finance Corporation of Travis County, recipient of the ASES Energy Equity and Community Impact AwardDarien Clary, Austin ISD, recipient of the ASES Clean Energy Innovation and Education AwardBrigid Shea, Travis County Commissioner, recipient of the ASES Host County Renewable Energy Leadership Award

SOLAR 2026 will take place October 19–21 at the Palmer Events Center in Austin, bringing together clean energy professionals, researchers, educators, policymakers and advocates. Register and view the full program at ases.org/conference.

About ASES: The American Solar Energy Society (ASES) is the nation’s longest-serving solar energy advocacy organization. ASES is a 501(c)(3) nonprofit advancing sustainable living and a 100% clean energy future through solar energy education, research, workforce development and community-based deployment. Guided by justice, equity, diversity and inclusion, ASES connects science, industry, policy and the public through Solar Today magazine, the e-newsletter Solar@Work, Webinars, the ASES National Solar Conference, and the ASES National Solar Tour. Learn more at ases.org.

View original content to download multimedia:https://www.prnewswire.com/news-releases/ases-to-honor-six-austin-area-clean-energy-leaders-at-solar-2026-302906029.html

SOURCE American Solar Energy Society

Continue Reading

Technology

Xodus Medical Announces Agreement to Be Acquired by STERIS (NYSE: STE)

Published

on

By

PITTSBURGH, Oct. 12, 2026 /PRNewswire/ — Xodus Medical, a leading developer and manufacturer of innovative surgical safety solutions, today announced that it has entered into an agreement to be acquired by STERIS, a global provider of products and services that support patient care with an emphasis on infection prevention.

The acquisition represents a significant milestone in Xodus Medical’s more than 30-year history, bringing together two organizations with a shared commitment to advancing patient safety, supporting healthcare professionals, and delivering innovative solutions to the surgical environment. As part of a larger global organization, Xodus Medical looks forward to expanding its reach, leveraging complementary capabilities, and delivering even greater value to its customers.

Equally important is the strong cultural alignment between the two companies. Both organizations share a dedication to product excellence, continuous improvement, and building lasting relationships with the healthcare professionals they serve. “Joining STERIS represents an exciting new chapter for Xodus Medical and an opportunity to build upon everything our talented team has accomplished over the past three decades,” said Craig Kaforey, Chief Executive Officer of Xodus Medical. “Together, we see tremendous potential to deliver even greater value to our customers by combining our innovative products and expertise with STERIS’s extensive resources, industry knowledge, and established market presence. Just as importantly, we believe our shared values and commitment to excellence will create meaningful opportunities for our employees to grow and develop as part of a global organization. I am incredibly proud of what our team has accomplished and excited about what lies ahead.”

STERIS is approximately $6 billion in revenue, with 18,000 Associates focused on providing innovative healthcare and life science products and services around the globe. “Xodus Medical’s product portfolio complements and expands STERIS’s offering, particularly by adding consumables used in the operating room. Its focus on products that make surgery safer aligns closely with our mission to help our Customers create a healthier and safer world,” said Dan Carestio, President and Chief Executive Officer of STERIS. “The business has demonstrated an ability to grow at double-digit rates with its specialty product portfolio, a steady stream of new products, and a highly effective commercial team. We look forward to welcoming the Xodus Medical team to STERIS and working together to enhance our service to our customers and value for our shareholders.”

Throughout its history, Xodus Medical has remained focused on its mission of Making Surgery Safer™. The company believes joining STERIS will further strengthen its ability to support healthcare providers with differentiated solutions that enhance patient safety and improve surgical outcomes.

Advisors

Goldman Sachs & Co. LLC is serving as exclusive financial advisor to STERIS, and Jones Day is serving as legal counsel. J.P. Morgan is serving as exclusive financial advisor to Xodus Medical, and Morgan, Lewis & Bockius LLP is serving as legal counsel.

About STERIS

STERIS is a leading global provider of products and services that support patient care with an emphasis on infection prevention. WE HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science products and services around the globe. For more information, visit www.steris.com.

About Xodus Medical

Founded in 1993 and headquartered near Pittsburgh, Pennsylvania, Xodus Medical is a leading developer and manufacturer of innovative medical devices dedicated to Making Surgery Safer™. The company’s comprehensive portfolio of proprietary surgical safety technologies, including its flagship Pink Pad® patient positioning systems, serves hospitals worldwide. Xodus Medical has established itself as a trusted partner to healthcare professionals and a recognized leader in perioperative patient safety. For more information, visit www.xodusmedical.com.

View original content:https://www.prnewswire.com/news-releases/xodus-medical-announces-agreement-to-be-acquired-by-steris-nyse-ste-302906035.html

SOURCE Xodus Medical

Continue Reading

Trending